Oct 17 (Reuters) - Mauna Kea Technologies SA ALMKT.PA :
* PUBLICATION OF POSITIVE RESULTS OF A RANDOMIZED CONTROLLED
TRIAL
IN FIELD OF INTERSTITIAL LUNG DISEASE
* MAUNA KEA TECHNOLOGIES ANNOUNCES PUBLICATION OF POSITIVE
RESULTS
OF A RANDOMIZED CONTROLLED TRIAL IN FIELD OF INTERSTITIAL LUNG
DISEASE
* SUPERIORITY IN PRECISION AND SAFETY OF CELLVIZIO-GUIDED
TRANSBRONCHIAL CRYOBIOPSY FOR DIAGNOSIS OF INTERSTITIAL LUNG
DISEASE (ILD)
* TRIAL, CONDUCTED BETWEEN JANUARY AND NOVEMBER 2022,
INVOLVED 80
PATIENTS WITH UNDIAGNOSED ILD AND REQUIRING A BIOPSY
Source text for Eikon: ID:nBw16KDHGa
Further company coverage: ALMKT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))